feed,title,long_url,short_url
Benzinga,"Baidu, iQIYI Explore Options After US SEC Added Them To Provisional List Pending Audit Review",https://benzinga.com/government/22/03/26394254/baidu-iqiyi-explore-options-after-us-sec-added-them-to-provisional-list-pending-audit-review,https://bit.ly/3K3x05u
Benzinga,Clovis Oncology's Rubraca Significantly Improves PFS In Ovarian Cancer Regardless Of Biomarker Status,https://benzinga.com/general/biotech/22/03/26394815/clovis-oncologys-rubraca-significantly-improves-pfs-in-ovarian-cancer-regardless-of-biomarker-sta,https://bit.ly/38at2cZ
